Intra-Cellular Therapies Cash from Financing (TTM) Analysis

Intra-Cellular Therapies Inc (ITCI)

70.35 -2.32 (-3.19%) USD | NASDAQ | May 02, 16:00

70.35 0.00 (0.00%) After-Hours: 19:06

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	17.81M
September 30, 2023	16.99M
June 30, 2023	20.07M
March 31, 2023	16.98M
December 31, 2022	455.16M
September 30, 2022	460.89M
June 30, 2022	455.82M
March 31, 2022	451.90M
December 31, 2021	11.52M
September 30, 2021	7.240M
June 30, 2021	385.14M
March 31, 2021	388.04M
December 31, 2020	664.18M
September 30, 2020	663.33M
June 30, 2020	284.99M
March 31, 2020	280.77M
December 31, 2019	3.236M
September 30, 2019	0.6287M
June 30, 2019	0.6317M

Date	Value
March 31, 2019	0.3786M
December 31, 2018	0.6852M
September 30, 2018	162.63M
June 30, 2018	162.47M
March 31, 2018	162.47M
December 31, 2017	162.36M
September 30, 2017	-124.74M
June 30, 2017	0.3605M
March 31, 2017	0.5382M
December 31, 2016	0.4777M
September 30, 2016	125.77M
June 30, 2016	328.18M
March 31, 2016	328.17M
December 31, 2015	449.89M
September 30, 2015	449.63M
June 30, 2015	122.16M
March 31, 2015	122.15M
December 31, 2014	115.72M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.6287M

Minimum

Sep 2019

664.18M

Maximum

Dec 2020

241.33M

Average

280.77M

Median

Mar 2020

Cash from Financing (TTM) Benchmarks